Featured Content

Newsletters and Deep Dive
digital magazine

Latest News

News
Man in wheelchair

ACC25: Ozempic shows its value in PAD

Novo Nordisk's Ozempic has been shown to improve walking distance in people with diabetes and peripheral artery disease in the STRIDE trial.

Views & Analysis

White Papers & Webinar

R&D
Life Sciences Industry Report - Part 6

Life Sciences Industry Report - Part 6

There are some 7,000 known rare diseases in the world, yet, multiple challenges and unmet needs remain when it comes to therapies for these diseases.

Podcasts & Video

Partner Content